Mahmood Haghighat

Mahmood Haghighat

Auto-generated profile, based on publicly available information

Mahmood Haghighat

Gastroenterohepatology Research Center, Nemazee Teaching Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in World Journal of Gastroenterology
Verified
Journal Article
Closed access
MHMahmood Haghighat
Mahmood Haghighat
SRSeyed Mohammad Rafie
Seyed Mohammad Rafie
SDSeyed Mohsen Dehghani
Seyed Mohsen Dehghani
GFGholam Hossein Fallahi
Gholam Hossein Fallahi
MNMarzieh Nejabat
Marzieh Nejabat
To evaluate the clinical presentation, response to prophylactic therapy and outcome of children with cyclic vomiting syndrome (CVS) in Shiraz, Iran. During a period of 11 years (March 1994 to March 2005), 181 consecutive children with a final diagnosis of CVS were evaluated, treated and followed in our center. Patients were randomized to receive either amitriptyline or propranolol as prophylactic treatments. There were 88 boys and 93 girls with mean age of onset of symptoms of 4.9 +/- 3.3 years (range, neonatal period to 14 years), the mean age at final diagnosis was 6.9 years (range, 1.5 to 14), and the mean duration between the onset of the first attack and the final diagnosis of CVS was 2 +/- 1.81 years (range, 1/6 to 8). The mean duration of each attack was 4.26 days (range, from few hours to 10 d) and the mean interval between the attacks was 1.8 mo (range, 1 wk to 12 mo). The time of onset of the attacks was midnight to early morning in about 70% of cases. Amitriptyline was effective in 46 out of 81 (56%) patients (P < 0.001). Propranolol appeared to have a superior action and was effective in 74 out of 83 (92%) patients (P < 0.0001). There is a significant lag time between the onset of clinical symptoms and the final diagnosis of CVS in our area. In patients with typical clinical presentations of CVS, who are examined by an experienced physician, invasive workup is not necessary. Propranolol appears more effective than amitriptyline for prophylactic use in children with CVS.

1 January 2006 in World Journal of Gastroenterology
Verified
Journal Article
Open access
SDSeyed Mohsen Dehghani
Seyed Mohsen Dehghani
MHMahmood Haghighat
Mahmood Haghighat
MIMohammad Hadi Imanieh
Mohammad Hadi Imanieh
BGBita Geramizadeh
Bita Geramizadeh
AIM: To evaluate different methods in differentiating idiopathic neonatal hepatitis from biliary atresia. METHODS: Sixty-five infants with cholestatic jaundice and final diagnosis of idiopathic neonatal hepatitis and biliary atresia were studied prospectively from September 2003 to March 2006. A thorough history and physical examination were undertaken and the liver enzymes were examined. All cases underwent abdominal ultrasonography, hepatobiliary scintigraphy, and percutaneous liver biopsy. The accuracy, sensitivity, specificity and predictive values of these various methods were compared. RESULTS: There were 34 girls and 31 boys, among them 46 subjects had idiopathic neonatal hepatitis (age, 61 ± 17 d) and 19 had biliary atresia (age, 64 ± 18 d). The mean age at onset of jaundice was significantly lower in cases of biliary atresia when compared to idiopathic neonatal hepatitis cases (9 ± 13 d vs 20 ± 21 d; P = 0.032). The diagnostic accuracy of different methods was as follows: liver biopsy, 96.9%; clinical evaluation, 70.8%; ultrasonography, 69.2%; hepatobiliary scintigraphy, 58.5%; and liver enzymes, 50.8%. CONCLUSION: Our results indicate that clinical evaluation by an experienced pediatric hepatologist and a biopsy of the liver are considered as the most reliable methods to differentiate idiopathic neonatal hepatitis and biliary atresia.

1 April 2006 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
AAAbdolvahab Alborzi
Abdolvahab Alborzi
JSJafar Soltani
Jafar Soltani
BPBahman Pourabbas
Bahman Pourabbas
BOBarat Oboodi
Barat Oboodi
MHMahmood Haghighat
Mahmood Haghighat
MRMahmood Rashidi
Mahmood Rashidi

1 February 2008 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
SDSeyed Mohsen Dehghani
Seyed Mohsen Dehghani
MHMahmood Haghighat
Mahmood Haghighat
MIMohammad Hadi Imanieh
Mohammad Hadi Imanieh
BGBita Geramizadeh
Bita Geramizadeh
Background Solitary rectal ulcer syndrome (SRUS) is an uncommon rectal disorder that can present with bleeding, passage of mucus, straining during defecation, and a sense of incomplete evacuation. As it is rare, its incidence is uncertain, but has been estimated to be one in 100 000 in adults. A few cases, however, have been reported in pediatric age groups. Patients and Methods During a period of 2.5 years, from September 2003 to February 2006, 12 consecutive children with prolonged intermittent fresh blood on the surface of stools or mixed with it were diagnosed with SRUS. All cases were treated initially with sucralfate enema and followed up. Results Nine boys and three girls were studied. The mean age of patients was 9.25±2.67 years. The mean duration from beginning of symptoms to final diagnosis was 6.4±6.6 months. All cases had normal growth and none had any evidence of bleeding diathesis, significant anemia, bacterial or parasitic infection, or any other systemic diseases to explain their problem. Seven cases responded to sucralfate enema, one to salicylate enema, one to corticosteroid enema, and two cases became asymptomatic after injection of corticosteroid around and within the ulcers. One patient underwent rectopexy. Conclusion As the clinical presentation varies, the diagnosis requires a high index of suspicion on the part of both the clinician and the pathologist. This entity is not rare in children in our center, which may be due to the traditional method of defecation (in squatting position). Furthermore, we conclude that sucralfate enema is a suitable initial medical treatment for children with SRUS, and that injection of corticosteroid is a new treatment modality that requires further research to establish its efficacy.

1 April 2013 in Annals of Saudi Medicine
Verified
Journal Article
Open access
SDSeyed Mohsen Dehghani
Seyed Mohsen Dehghani
MHMahmood Haghighat
Mahmood Haghighat
AMArash Mobayen
Arash Mobayen
ARAbbas Rezaianzadeh
Abbas Rezaianzadeh
BGBita Geramizadeh
Bita Geramizadeh
Other than its classic presentation, celiac disease can be completely asymptomatic in a proportion of the general population. Subjects with silent celiac disease are at risk of potential complications of the disease, which indicates the importance of early diagnosis. In this study we investigated the prevalence of silent celiac disease in healthy children in our area. Cross-sectional screening of healthy children in Shiraz city. Fifteen hundred school children, 6 to 12 years of age in Shiraz (Southern Iran) were screened for celiac disease through serological testing of their serum anti-tissue transglutaminase immunoglobulin A antibodies. A small intestinal biopsy was performed for children with positive serology tests and pathologic reports were given according to the modified Marsh criteria. Of the total students included, with a mean (SD) age of 9.5 (1.3) years, 30 subjects had positive anti-tissue transglutaminase immunoglobulin A antibodies, resulting in a total seropositivity of 2%. The prevalence of biopsy proven celiac disease (silent celiac) was 0.6%. As in many other regions worldwide, this study estimated a relatively high prevalence of silent celiac disease in children in our area, citing the disease as an important health problem in our region.

20 February 2009 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
MIMohammad Hadi Imanieh
Mohammad Hadi Imanieh
SDSeyed Mohsen Dehghani
Seyed Mohsen Dehghani
MBMohammad Hadi Bagheri
Mohammad Hadi Bagheri
VEVahid Emad
Vahid Emad
MHMahmood Haghighat
Mahmood Haghighat
FGFarshid Gheisari
Farshid Gheisari